Severe asthma in children is a complicated disorder characterized by ongoing symptoms and persistent airway inflammation despite treatment with high doses of inhaled and oral corticosteroids. Although knowledge of asthma and its associated mechanisms has increased substantially over the past decade, significant gaps remain about the determinants of severe asthma in children and the progression of the disorder across the lifespan. This review highlights recent insights into severe asthma in children derived from the National Heart, Lung, and Blood Institute's Severe Asthma Research Program (SARP), with an emphasis on age-specific findings and differences from severe asthma in adults. While the existence of a true severe asthma phenotype in children is subject to some debate, given the results of SARP and other investigators, we conclude that there is indeed a subgroup of children with severe asthma who have extreme morbidity and differentiating clinical features that are identifiable very early in life. However, unlike adults with severe asthma, children with severe asthma are more likely to fall in a more narrow cluster that is characterized by marked atopy and reversible airflow obstruction. While SARP has advanced knowledge of severe asthma in children, considerable gaps remain for which additional studies are needed.
Get full access to this article
View all access options for this article.
References
1.
American Lung Association Epidemiology and Statistics Unit RaPSD. Trends in Asthma Morbidity and Mortality. February 2010. www.lungusa.org.
2.
BossleyCJ, SaglaniS, KavanaghC, PayneDN, WilsonN, TsartsaliLet al.Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma. Eur Respir J, 2009; 34:1052–1059.
3.
FitzpatrickAM, GastonBM, ErzurumSC, TeagueWG. Features of severe asthma in school-age children: atopy and increased exhaled nitric oxide. J Allergy Clin Immunol, 2006; 118:1218–1225.
4.
BhavsarP, HewM, KhorasaniN, TorregoA, BarnesPJ, AdcockIet al.Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax, 2008; 63:784–790.
5.
HewM, BhavsarP, TorregoA, MeahS, KhorasaniN, BarnesPJet al.Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med, 2006; 174:134–141.
6.
MeyersDA, PostmaDS, StineOC, KoppelmanGH, AmplefordEJ, JongepierHet al.Genome screen for asthma and bronchial hyperresponsiveness: interactions with passive smoke exposure. J Allergy Clin Immunol, 2005; 115:1169–1175.
7.
ten BrinkeA, OuwerkerkME, ZwindermanAH, SpinhovenP, BelEH. Psychopathology in patients with severe asthma is associated with increased health care utilization. Am J Respir Crit Care Med, 2001; 163:1093–1096.
8.
GodardP, ChanezP, SiraudinL, NicoloyannisN, DuruG. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J, 2002; 19:61–67.
9.
SmithDH, MaloneDC, LawsonKA, OkamotoLJ, BattistaC, SaundersWB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med, 1997; 156,3 Pt 1:787–793.
10.
McKenzieSA, BushA. Difficult asthma in children. Thorax, 2002; 57:915–916.
11.
BushA, HedlinG, CarlsenKH, de BenedictisF, Lodrup-CarlsenK, WilsonN. Severe childhood asthma: a common international approach?Lancet, 2008; 372:1019–1021.
12.
MooreWC, BleeckerER, Curran-EverettD, ErzurumSC, AmeredesBT, BacharierLet al.Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol, 2007; 119:405–413.
13.
National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol, 2007; 120,5 Suppl:S94–S138.
14.
LiardR, LeynaertB, ZureikM, BeguinFX, NeukirchF. Using Global Initiative for Asthma guidelines to assess asthma severity in populations. Eur Respir J, 2000; 16:615–620.
15.
Von MutiusE. Presentation of new GINA guidelines for paediatrics. The Global Initiative on Asthma. Clin Exp Allergy, 2000; 30,Suppl 1:6–10.
16.
Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med, 2000; 162:2341–2351.
17.
MartinezFD, WrightAL, TaussigLM, HolbergCJ, HalonenM, MorganWJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med, 1995; 332:133–138.
18.
SpycherBD, SilvermanM, BrookeAM, MinderCE, KuehniCE. Distinguishing phenotypes of childhood wheeze and cough using latent class analysis. Eur Respir J, 2008; 31:974–981.
19.
TaussigLM, WrightAL, MorganWJ, HarrisonHR, RayCG. The Tucson Children's Respiratory Study. I. Design and implementation of a prospective study of acute and chronic respiratory illness in children. Am J Epidemiol, 1989; 129:1219–1231.
Castro-RodriguezJA, HolbergCJ, WrightAL, MartinezFD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med, 2000; 162,4 Pt 1:1403–1406.
22.
HalandG, CarlsenKC, SandvikL, DevulapalliCS, Munthe-KaasMC, PettersenMet al.Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med, 2006; 355:1682–1689.
23.
SternDA, MorganWJ, WrightAL, GuerraS, MartinezFD. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet, 2007; 370:758–764.
24.
GuerraS, LohmanIC, HalonenM, MartinezFD, WrightAL. Reduced interferon gamma production and soluble CD14 levels in early life predict recurrent wheezing by 1 year of age. Am J Respir Crit Care Med, 2004; 169:70–76.
25.
MartinezFD, SternDA, WrightAL, HolbergCJ, TaussigLM, HalonenM. Association of interleukin-2 and interferon-gamma production by blood mononuclear cells in infancy with parental allergy skin tests and with subsequent development of atopy. J Allergy Clin Immunol, 1995; 96,5 Pt 1:652–660.
26.
TangML, KempAS, ThorburnJ, HillDJ. Reduced interferon-gamma secretion in neonates and subsequent atopy. Lancet, 1994; 344:983–985.
27.
SaglaniS, MalmstromK, PelkonenAS, MalmbergLP, LindahlH, KajosaariMet al.Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med, 2005; 171:722–727.
28.
SaglaniS, PayneDN, ZhuJ, WangZ, NicholsonAG, BushAet al.Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med, 2007; 176:858–864.
29.
HaukPJ, KrawiecM, MurphyJ, BoguniewiczJ, SchiltzA, GolevaEet al.Neutrophilic airway inflammation and association with bacterial lipopolysaccharide in children with asthma and wheezing. Pediatr Pulmonol, 2008; 43:916–923.
30.
MarguetC, BocquelN, BenichouJ, BasuyauJP, HellotMF, CoudercLet al.Neutrophil but not eosinophil inflammation is related to the severity of a first acute epidemic bronchiolitis in young infants. Pediatr Allergy Immunol, 2008; 19:157–165.
31.
MarguetC, Jouen-BoedesF, DeanTP, WarnerJO. Bronchoalveolar cell profiles in children with asthma, infantile wheeze, chronic cough, or cystic fibrosis. Am J Respir Crit Care Med, 1999; 159,5 Pt 1:1533–1540.
32.
HeymannPW, Platts-MillsTA, JohnstonSL. Role of viral infections, atopy and antiviral immunity in the etiology of wheezing exacerbations among children and young adults. Pediatr Infect Dis J, 2005; 24,11 Suppl:S217–S222discussion S20–S21.
33.
PanickarJ, LakhanpaulM, LambertPC, KeniaP, StephensonT, SmythAet al.Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med, 2009; 360:329–338.
34.
GuilbertTW, MorganWJ, ZeigerRS, MaugerDT, BoehmerSJ, SzeflerSJet al.Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med, 2006; 354:1985–1997.
35.
BacharierLB, GuilbertTW, ZeigerRS, StrunkRC, MorganWJ, LemanskeRFJr.et al.Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma. J Allergy Clin Immunol, 2009; 123:1077–1082, 1082.e1–5.
ChippsBE, SzeflerSJ, SimonsFE, HaselkornT, MinkDR, DenizYet al.Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma. J Allergy Clin Immunol, 2007; 119:1156–1163.
38.
JenkinsHA, CherniackR, SzeflerSJ, CovarR, GelfandEW, SpahnJD. A comparison of the clinical characteristics of children and adults with severe asthma. Chest, 2003; 124:1318–1324.
39.
ZeigerRS, ChippsBE, HaselkornT, RasouliyanL, SimonsFE, FishJE. Comparison of asthma exacerbations in pediatric and adult patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol, 2009; 124:1106–1108.
40.
PayneDN, WilsonNM, JamesA, HablasH, AgrafiotiC, BushA. Evidence for different subgroups of difficult asthma in children. Thorax, 2001; 56:345–350.
41.
SearsMR, GreeneJM, WillanAR, WiecekEM, TaylorDR, FlanneryEMet al.A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med, 2003; 349:1414–1422.
42.
RasmussenF, TaylorDR, FlanneryEM, CowanJO, GreeneJM, HerbisonGPet al.Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med, 2002; 165:1480–1488.
43.
Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med, 2000; 343:1054–1063.
44.
CovarRA, SpahnJD, MurphyJR, SzeflerSJ. Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med, 2004; 170:234–241.
45.
StrunkRC, WeissST, YatesKP, TonasciaJ, ZeigerRS, SzeflerSJ. Mild to moderate asthma affects lung growth in children and adolescents. J Allergy Clin Immunol, 2006; 118:1040–1047.
46.
DekkersBG, MaarsinghH, MeursH, GosensR. Airway structural components drive airway smooth muscle remodeling in asthma. Proc Am Thorac Soc, 2009; 6:683–692.
DaviesDE. The role of the epithelium in airway remodeling in asthma. Proc Am Thorac Soc, 2009; 6:678–682.
49.
BushA, Menzies-GowA. Phenotypic differences between pediatric and adult asthma. Proc Am Thorac Soc, 2009; 6:712–719.
50.
FitzpatrickAM, HigginsM, HolguinF, BrownLA, TeagueWG. The molecular phenotype of severe asthma in children. J Allergy Clin Immunol, 2010; 125:851–857.e18.
51.
Tillie-LeblondI, de BlicJ, JaubertF, WallaertB, ScheinmannP, GossetP. Airway remodeling is correlated with obstruction in children with severe asthma. Allergy, 2008; 63:533–541.
52.
JustJ, FournierL, MomasI, ZambettiC, SahraouiF, GrimfeldA. Clinical significance of bronchoalveolar eosinophils in childhood asthma. J Allergy Clin Immunol, 2002; 110:42–44.
53.
de BlicJ, Tillie-LeblondI, TonnelAB, JaubertF, ScheinmannP, GossetP. Difficult asthma in children: an analysis of airway inflammation. J Allergy Clin Immunol, 2004; 113:94–100.
54.
PayneDN, RogersAV, AdelrothE, BandiV, GuntupalliKK, BushAet al.Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med, 2003; 167:78–82.
55.
PayneDN, QiuY, ZhuJ, PeacheyL, ScallanM, BushAet al.Airway inflammation in children with difficult asthma: relationships with airflow limitation and persistent symptoms. Thorax, 2004; 59:862–869.
56.
PayneDN, AdcockIM, WilsonNM, OatesT, ScallanM, BushA. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med, 2001; 164,8 Pt 1:1376–1381.
57.
LexC, PayneDN, ZacharasiewiczA, LiAM, WilsonNM, HanselTTet al.Sputum induction in children with difficult asthma: safety, feasibility, and inflammatory cell pattern. Pediatr Pulmonol, 2005; 39:318–324.
58.
CovarRA, StrunkR, ZeigerRS, WilsonLA, LiuAH, WeissSet al.Predictors of remitting, periodic, and persistent childhood asthma. J Allergy Clin Immunol, 2010; 125:359–366.e3.
59.
LimbSL, BrownKC, WoodRA, WiseRA, EgglestonPA, TonasciaJet al.Adult asthma severity in individuals with a history of childhood asthma. J Allergy Clin Immunol, 2005; 115:61–66.
60.
SternDA, MorganWJ, HalonenM, WrightAL, MartinezFD. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet, 2008; 372:1058–1064.
61.
VonkJM, PostmaDS, BoezenHM, GrolMH, SchoutenJP, KoeterGHet al.Childhood factors associated with asthma remission after 30 year follow up. Thorax, 2004; 59:925–929.
62.
van Den ToornLM, PrinsJB, OverbeekSE, HoogstedenHC, de JongsteJC. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med, 2000; 162,3 Pt 1:953–957.
63.
TaylorDR, CowanJO, GreeneJM, WillanAR, SearsMR. Asthma in remission: can relapse in early adulthood be predicted at 18 years of age?Chest, 2005; 127:845–850.
64.
RasmussenF, TaylorDR, FlanneryEM, CowanJO, GreeneJM, HerbisonGPet al.Risk factors for hospital admission for asthma from childhood to young adulthood: a longitudinal population study. J Allergy Clin Immunol, 2002; 110:220–227.
65.
SorknessRL, BleeckerER, BusseWW, CalhounWJ, CastroM, ChungKFet al.Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol, 2008; 104:394–403.
66.
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J, 2003; 22:470–477.
67.
VrugtB, WilsonS, UnderwoodJ, BronA, de BruynR, BraddingPet al.Mucosal inflammation in severe glucocorticoid-dependent asthma. Eur Respir J, 1999; 13:1245–1252.
68.
WenzelSE. Asthma: defining of the persistent adult phenotypes. Lancet, 2006; 368:804–813.
69.
MooreWC, MeyersDA, WenzelSE, TeagueWG, LiH, LiXet al.Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med, 2010; 181:315–323.
70.
MirandaC, BusackerA, BalzarS, TrudeauJ, WenzelSE. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol, 2004; 113:101–108.
71.
WenzelSE, SchwartzLB, LangmackEL, HallidayJL, TrudeauJB, GibbsRLet al.Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med, 1999; 160:1001–1008.
